Ireland - English - HPRA (Health Products Regulatory Authority)

pco manufacturing ltd. - fenofibrate - film-coated tablet - 145 milligram(s) - fibrates; fenofibrate - serum lipid reducing agents / cholesterol and triglycerides reducers / fibrates. - it is indicated for: treatment of severe hypertriglyceridaemia with or without low hdl cholesterol,
mixed hyperlipidaemia when a statin is contraindicated or not tolerated,
mixed hyperlipidaemia in patients at high cardiovascular risk in addition to a statin when triglycerides and hdl cholesterol are not adequately controlled.

Ireland - English - HPRA (Health Products Regulatory Authority)

primecrown 2010 limited - fenofibrate - film-coated tablet - 145 milligram(s) - fibrates; fenofibrate - serum lipid reducing agents / cholesterol and triglycerides reducers / fibrates. - it is indicated as an adjunct to diet and other non-pharmacological treatment (e.g. exercise, weight reduction) for the following: severe hypertriglyceridaemia with or without low hdl cholesterol, mixed hyperlipidaemia when a statin is contraindicated or not tolerated, mixed hyperlipidaemia in patients at high cardiovascular risk in addition to a statin when triglycerides and hdl cholesterol are not adequately controlled.

Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ltd - fenofibrate - film coated tablet - 145 milligram - fibrates - serum lipid reducing agents / cholesterol and triglycerides reducers / fibrates - it is indicated as an adjunct to diet and other non-pharmacological treatment (e.g. exercise, weight reduction) for the following:
treatment of severe hypertriglyceridaemia with or without low hdl cholesterol.
mixed hyperlipidaemia when a statin is contraindicated or not tolerated.
mixed hyperlipidaemia in patients at high cardiovascular risk in addition to a statin when triglycerides and hdl cholesterol are not adequately controlled.

Ireland - English - HPRA (Health Products Regulatory Authority)

mylan ire healthcare limited - fenofibrate - film-coated tablet - 145 milligram(s) - fibrates; fenofibrate

Australia - English - Department of Health (Therapeutic Goods Administration)

zifam pinnacle pty ltd - calcium pantothenate, quantity: 50 mg (equivalent: pantothenic acid, qty 45 mg); folic acid, quantity: 500 microgram; pyridoxine hydrochloride, quantity: 50 mg (equivalent: pyridoxine, qty 43 mg); ascorbic acid, quantity: 250 mg; potassium gluconate, quantity: 13 mg (equivalent: potassium, qty 2 mg); riboflavine, quantity: 50 mg; betacarotene, quantity: 3 mg; zinc gluconate, quantity: 38.5 mg (equivalent: zinc, qty 5 mg); biotin, quantity: 50 microgram; calcium amino acid chelate, quantity: 50 mg (equivalent: calcium, qty 10 mg); nicotinamide, quantity: 50 mg; cyanocobalamin, quantity: 50 microgram; inositol, quantity: 50 mg; iron amino acid chelate, quantity: 10 mg (equivalent: iron, qty 1 mg); magnesium amino acid chelate, quantity: 50 mg (equivalent: magnesium, qty 10 mg); chromic chloride hexahydrate, quantity: 50 microgram (equivalent: chromium, qty 10 microgram); potassium iodide, quantity: 197 microgram (equivalent: potassium, qty 46 microgram; equivalent: iodine, qty 150 microgram); d-alpha-tocopheryl acid succinate, quantity: 61.9 mg (equivalent: d-alpha-tocopherol, qty 75 iu); thiamine hydrochloride, quantity: 50 mg; manganese amino acid chelate, quantity: 5 mg (equivalent: manganese, qty 500 microgram); colecalciferol, quantity: 0.01 mg - tablet, modified release - excipient ingredients: glyceryl monostearate; calcium hydrogen phosphate dihydrate; gelatin; maltodextrin; colloidal anhydrous silica; modified food starch; maize starch; dl-alpha-tocopherol; purified water; povidone; calcium carbonate; magnesium stearate; hydrogenated vegetable oil; hypromellose; titanium dioxide; purified talc; xanthan gum; polyvinyl alcohol; lecithin; silicon dioxide; sucrose; hydrolysed gelatin; hydrogenated soya oil; iron oxide yellow; iron oxide red; macrogol 3350; iron oxide black - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; maintain/support energy levels ; helps convert (state food) into energy ; maintain/support energy production ; maintain/support healthy eye function ; maintain/support eye health ; maintain/support body mucous membrane health ; maintain/support general health and wellbeing ; aids/assists teeth development ; maintain/support nail health/strength/thickness ; maintain/support connective tissue health ; maintain/support bone health ; aids/assists healthy bone development/growth/building ; help maintain/support bone mineralisation ; maintain/support red blood cell health ; aid/assist/helps oxygen transport to body tissues ; helps maintain/support haemoglobin formation/synthesis ; maintain/support cardiovascular system health ; maintain/support healthy cardiovascular system function ; maintain/support heart health ; maintain/support blood capillary health ; maintain/support immune system health ; maintain/support healthy immune system function ; maintain/support healthy muscle contraction function ; maintain/support muscle function ; aid/assist/helps glucose/sugar/carbohydrate metabolism ; aid/assist/helps protein synthesis in the body ; maintain/support absorption of dietary (state vitamin/mineral/nutrient) ; maintain/support (state vitamin/mineral/nutrient) levels in the body ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; aid/assist/helps metabolism of (state vitamin/mineral/nutrient) ; aids/assists the body to cope with environmental stress ; support healthy stress response in the body ; maintain/support nerve conduction ; aid/assist/helps synthesis of neurotransmitters ; maintain/support nervous system health ; maintain/support nervous system function ; maintain/support testosterone level ; maintain/support skin health ; maintain/support wound healing

Australia - English - Department of Health (Therapeutic Goods Administration)

future medical group pty ltd - 43167 - acetabular shell - furlong? h-a.c. acetabular cups are made of titanium alloy coated with hydroxyapatite ceramic coating. they are intended for press-fit use without cement where there is adequate bonestock to support the device and are directly fixated through their own peripheral thread. the screw holes permit the use of titanium alloy screws for additional fixation. bone in-growth with union of the hac coating and the host bone will result in complete fixation. for use with biolox delta ceramic bearing only. the furlong hac supravit coated csf plus cup ceramic bearing cup is a component of the furlong? h-a.c primary total hip replacement system, indicated by, but not limited to the following conditions: * severely painful and/or disabled joint from osteoarthritis, traumatic arthritis, rheumatoid arthritis, or congenital hip dysplasia. * avascular necrosis of the femoral head. * acute traumatic fracture of the femoral head or neck. * failed previous hip surgery including joint reconstruction, internal fixation, arthrodesis, hemiarthroplasty, surface replacement arthroplasty, or total hip replacement. * certain cases of ankylosis.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

f.a. herbs sdn.bhd. - silybum marianum/milk thistle; curcumae domestica rhizoma -

Bangladesh - English - DGDA (Directorate General of Drug Administration)

drug international ltd. - ascorbic acid + biotin + boron + calcium + chromium + copper + cyanocobalamin + elemental iron + folic acid + iodine + lutein + magnesium + manganese + molybdenum + niacin + nickel + pantothenic acid + phosphorous + pottassium + pyridoxine hydrochloride + riboflavin + selenium + silicon + tin + vanadium + vitamin a + vitamin b1 + vitamin d3 + vitamin e + vitamin k + zinc - soft gelatin capsule - 60 mg + 30 mcg + 150 mcg + 162 mg + 120 mcg + 2 mg + 6 mcg + 18 mg + 400 mcg + 150 mcg + 250 mcg + 100 mg + 2 mg + 75 mcg + 20 mg + 5 mcg + 10 mg + 109 mg + 80 mg + 2 mg + 1.7 mg + 20 mcg + 2 mg + 10 mcg + 10 mcg + 5000 iu + 1.5 mg + 400 iu + 30 iu + 25 mcg + 15 mg

Philippines - English - FDA (Food And Drug Administration)

jf draf pharmaceuticals corp.; distributor: beracah pharma phils., inc. - lithium carbonate - sustained released tablet - 450 mg

Egypt - English - EDA (Egyptian Drug Authority)

glaxo smithkline-egypt - capsule